Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 51

    NPPA told to revise prices of 3 Sun Pharma Formulations

    NPPA told to revise prices of 3 Sun Pharma Formulations

    Medical Dialogues Bureau30 Sept 2018 10:29 AM IST
    New Delhi: Through a recent order, the Department of Pharmaceutical has directed the NPPA to revise the prices of 3 Sun Pharma formulations, after the...
    Fighting Counterfeit Drugs: NITI Aayog, Oracle, Apollo Hospitals Strides Pharma Join Hands

    Fighting Counterfeit Drugs: NITI Aayog, Oracle, Apollo Hospitals Strides Pharma Join Hands

    Medical Dialogues Bureau29 Sept 2018 2:05 PM IST
    NITI Aayog has the partnership with Apollo Hospital, Oracle, Strides Pharma work to pilot a real drug supply chain using the blockchain software...
    Metropolis Healthcare to aim for Rs 2000 crore plus IPO: Report

    Metropolis Healthcare to aim for Rs 2000 crore plus IPO: Report

    Medical Dialogues Bureau28 Sept 2018 3:30 PM IST
    Mumbai: Metropolis Healthcare, one of the large players in the medical diagnostic segment with its chain pathology labs and diagnostics services has...
    Govt Issues Guidelines on Good Distribution Practices for pharmaceutical products, invites comments

    Govt Issues Guidelines on Good Distribution Practices for pharmaceutical products, invites comments

    Medical Dialogues Bureau27 Sept 2018 3:21 PM IST
    All the stakeholders are requested to forward their comments/ suggestions within a period of three weeks through e-mail to dci@nic.in...
    FIRST: Needle, syringe makers tell government to regulate their prices

    FIRST: Needle, syringe makers tell government to regulate their prices

    Medical Dialogues Bureau26 Sept 2018 3:41 PM IST
    New Delhi: All India Syringes and Needles Manufacturers Association (AISNMA) has written a letter to NELM on price capping of essential syringes and...
    USFDA completes inspection of Biocon drug substance unit at Bengaluru

    USFDA completes inspection of Biocon drug substance unit at Bengaluru

    Medical Dialogues Bureau25 Sept 2018 1:46 PM IST
    No ObservationsBanglore: Biotechnology major Biocon has said the inspection of its drug substance manufacturing site at Bengaluru campus by the US...
    Medical Device Companies will have to give compensation in case of adverse event: Govt proposes provision in law

    Medical Device Companies will have to give compensation in case of adverse event: Govt proposes provision in law

    Medical Dialogues Bureau24 Sept 2018 1:03 PM IST
    The move comes after complaints that patients had suffered due to faulty hip implants by a subsidiary of pharma giant Johnson and Johnson. New Delhi:...
    DOP rejects Review Petition of Lupin against ceiling price fixation for its combinations

    DOP rejects Review Petition of Lupin against ceiling price fixation for its combinations

    Medical Dialogues Bureau23 Sept 2018 12:39 PM IST
    Department of Pharmaceutical rejected the review petition of Lupin " Lupin has not implemented the price notification"New Delhi: Through a recent...
    CCI investigation points to unfair practices by 3 pharma companies

    CCI investigation points to unfair practices by 3 pharma companies

    Medical Dialogues Bureau22 Sept 2018 5:44 PM IST
    New Delhi: Three prominent pharmaceutical companies are now under the radar of the Competition Commission of India (CCI) has started an initial...
    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Medical Dialogues Bureau21 Sept 2018 1:32 PM IST
    Investment firm KKR, through its portfolio company Radiant Life Care Private Limited, will buy more than 266 million shares in Max Healthcare at Rs 80...
    FDC Ban: Avoid These Combinations of Paracetamol

    FDC Ban: Avoid These Combinations of Paracetamol

    Medical Dialogues Bureau20 Sept 2018 12:39 PM IST
    New Delhi: The Government of India recently prohibited the manufacture for sale, sale and distribution for human use, 328 fixed-dose combinations,...
    No coercive steps to be taken against drug firms for FDCs already in market: Delhi HC

    No coercive steps to be taken against drug firms for FDCs already in market: Delhi HC

    Medical Dialogues Bureau19 Sept 2018 11:41 AM IST
    No coercive steps are taken against FDC drug Indian pharma major Wockhardt for sale of stock, already in the market, of its anti-inflammatory medicine...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    300,000 doses of Mercks Ebola shot available for emergencies: GAVI Vaccine Alliance

    300,000 doses of Merck's Ebola shot available for emergencies: GAVI Vaccine Alliance

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok